Industry & Policy News

[Stat] The US president's order directs the Department of Health and Human Services to establish a safety program to receive reports of AI-related harms and unsafe practices — and take actions to remedy them.

[Nature Biotechnology] Armed with gene technologies and CAR-Ts, scientists are attempting to eliminate viruses that escape immune detection and lurk in tissues for years.

[NeuroTrigger (PR Newswire)] NeuroTrigger announced that its non-invasive muscle stimulation system has been granted 510(k) clearance by the US FDA for the prevention or retardation of disuse atrophy and muscle re-education to maintain or increase range of motion.

[NYU Langone Health] The Department of Pediatrics at NYU Langone Health has received $9.8 million from NYU Langone trustee Trudy Elbaum Gottesman and Robert W. Gottesman, founding donors of Sala Institute for Child and Family Centered Care.

[SparX Biopharmaceutical Corp. (Cision Newswire)] The company is primed to launch a Phase I clinical study, aiming to assess the safety, tolerability, and preliminary efficacy of SPX-303 in patients beleaguered by advanced or refractory solid tumors.

[Nature] Three cities in Colombia saw a dramatic fall in the incidence of dengue in the years following the introduction of mosquitoes carrying Wolbachia, a bacterium that prevents the insect from transmitting viruses. In neighbourhoods where the Wolbachia mosquitoes were well established, dengue incidence dropped by 94–97%.